Funding Opportunities

• Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
  (PAR-21-254)
  National Human Genome Research Institute
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is Oct 5,2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
  (PAR-21-255)
  National Human Genome Research Institute
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is Oct 16, 2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
  (PAR-21-256)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): August 30, 2021, July 14, 2022, July 13, 2023
• Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
  (PAR-21-288)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
  (PAR-21-289)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Clinical and Translational Science Award (UM1 Clinical Trial Optional)
  (PAR-21-293)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)
  (RFA-CA-21-041)
  National Cancer Institute
  Application Receipt Date(s): November 01, 2021
• Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed)
  (RFA-CA-21-042)
  National Cancer Institute
  Application Receipt Date(s): November 01, 2021
• Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed)
  (RFA-CA-21-048)
  National Cancer Institute
  Application Receipt Date(s): November 12, 2021; October 19, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.
• Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-21-049)
  National Cancer Institute
  Application Receipt Date(s): November 12, 2021
• Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
  (RFA-CA-21-050)
  National Cancer Institute
  Application Receipt Date(s): September 27, 2021
• Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed)
  (RFA-CA-21-051)
  National Cancer Institute
  Application Receipt Date(s): September 27, 2021
• Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed)
  (RFA-DA-22-018)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 18, 2022 No late applications will be accepted for this Funding Opportunity Announcement.
• Advancing Validated Drug Targets for Substance Use Disorders (R43/R44 - Clinical Trial Not Allowed)
  (RFA-DA-22-023)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 18, 2022 No late applications will be accepted for this Funding Opportunity Announcement.
• Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required)
  (RFA-DK-21-018)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 03, 2022
• BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed)
  (RFA-MH-21-235)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): November 09, 2021
• BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed)
  (RFA-MH-21-236)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): November 09, 2021
• BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed)
  (RFA-MH-21-237)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): November 09, 2021
• Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed)
  (RFA-NS-21-033)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): October 21, 2021 October 11, 2022 October 10, 2023